Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Viropharma, Inc.
(NQ:
VPHM
)
25.88
USD
+0.26 (+1.01%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
25.71
Bid (Size)
25.86 (1800)
Ask (Size)
25.88 (5400)
Prev. Close
25.62
Today's Range
25.42 - 25.88
52wk Range
19.02 - 31.36
Shares Outstanding
65,311,063
Dividend Yield
N/A
Top News
More News
ViroPharma To Participate In Two May Healthcare Investor Conferences
May 09, 2013
from
PR Newswire
Biota Pharmaceuticals Announces Changes to Its Board of Directors
May 06, 2013
from
GlobeNewswire News Releases
More News
Read More
Viropharma Crosses Below its 10-day MA (VPHM)
May 01, 2013
from
Comtex SmarTrend® News Briefs
Viropharma, Inc. (VPHM) Tops Q1 EPS by 11c
May 01, 2013
from
StreetInsider.com News Articles
ViroPharma Announces First Quarter 2013 Financial Results
May 01, 2013
from
PR Newswire
Trading Radar for 05/01: Facebook (FB), Clorox (CLX), MasterCard (MA), Chesapeake (CHK), Time Warner (TWX), Sands (LVS) Report
April 30, 2013
from
StreetInsider.com News Articles
ViroPharma To Release 2013 First Quarter Financial Results On May 1, 2013
April 25, 2013
from
PR Newswire
ViroPharma (VPHM) Updates on VP20621 Phase 2 in CDI; 54% of Patients Met Primary Endpoint
April 22, 2013
from
StreetInsider.com News Articles
Treatment With VP20621 (Non-Toxigenic Clostridium difficile; NTCD) In A Phase 2 Study Resulted In High Rates Of Colonization And Statistically Significant Reductions In Recurrence Of C. difficile Infe
April 22, 2013
from
PR Newswire
Lightning Round: AIG, Rockwell Collins & More
April 17, 2013
category
Hewlett/Packard Co
,
American Woodmark Corp
,
Lightning Round
, and 11 more.
from
CNBC.com News
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.